Treatment of neuropathic pain in Sierra Leone

Lacoux, Philippe; Lassalle, Xavier; McGoldrick, Pauline; Crombie, Iain K.; Macrae, W. A.

doi:10.1016/s0035-9203(03)80049-4

Cited by 8 publications

(10 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of phantom limb sensation, phantom limb pain, and stump pain are broadly in line with previous studies [4–6] given the small sample numbers in all these studies. This supports the accuracy of the data collected.…”

Section: Discussionsupporting

confidence: 88%

“…In a previous study of land mine accident survivors in Cambodia and Kurdistan, the Cambodian group had a 48% rate of chronic pain syndromes in a sample of 25 patients [4]. Another comparable study undertaken in Sierra Leone of 40 arm amputees had a phantom sensation rate of 93%, phantom limb pain rate of 33%, and stump pain rate of 100% [6]. An explanation for the relatively low level of phantom limb pain in the Sierra Leone study is suggested by Dijkstra et al.…”

Section: Discussionmentioning

confidence: 87%

See 1 more Smart Citation

Survey of Phantom Limb Pain, Phantom Sensation and Stump Pain in Cambodian and New Zealand Amputees

Byrne

2011

Pain Med

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 88%

Section: Discussionmentioning

confidence: 87%

Survey of Phantom Limb Pain, Phantom Sensation and Stump Pain in Cambodian and New Zealand Amputees

Byrne

2011

Pain Med

View full text Add to dashboard Cite

show abstract

“…The main causes of NeP vary globally [2]. In developing countries, infectious diseases such as Human Immunodeficiency Virus [3] and leprosy [4], trauma (due to war wounds and amputations) [5] and radiculopathies related to spinal column disease [2] are among the most common causes of NeP. In developed countries, diabetes is considered to be one of the most common causes of NeP [6].…”

Section: Introductionmentioning

confidence: 99%

Chronic diabetic peripheral neuropathic pain: psychometric properties of pain and physical function outcome measures

Mehta

Claydon

Mani

et al. 2018

Physical Therapy Reviews

View full text Add to dashboard Cite

Background: Diabetic peripheral neuropathy (DPN) not only produces severe pain, tingling, and numbness sensation in the involved limbs, but also limits physical function due to loss of sensation. There are no recommended methods for clinical situations to measure these signs and symptoms. Studies with high methodological quality use the modified Brief Pain Inventory for Diabetic Peripheral Neuropathic pain (mBPI-DPN) scale and the short form Screening of Activity Limitations and Safety Awareness (sSALSA) scale for measuring these symptoms in DPN population. In order to capture a real change in the variables of interest, the psychometric properties of that measure should be within acceptable limits. As these two measures were not assessed for all of the psychometric properties, there was a need for further evaluation. Methods: Data were collected (n ¼ 38 patients) in a longitudinal cohort study. Test-retest reliability (0-4 weeks) and Responsiveness-Minimal Clinically Important Difference (MCID) (0-12 weeks) were calculated between two sessions. Convergent validity was assessed (between mBPI-DPN pain interference and sSALSA scale). Results: Both measures demonstrated acceptable test-retest reliability (mBPI-DPN scale: ICC ¼ 0.61, SEM ¼ 12.92; the sSALSA scale: ICC ¼ 0.81, SEM ¼ 4.88) and convergent validity (Spearman's correlation coefficient r ¼ 0.62). The computational methods used in different methodologies to calculate MCID for the mBPI-DPN and the sSALSA scale were varied, hence the magnitude of derived MCID scores also varied. Conclusions: Our study have provided evidence to add to the scientific basis surrounding the use of mBPI-DPN and sSALSA scales in DPN population, but standardization of these measures in a larger population is required

show abstract

“…Due to the diversity of etiologies giving rise to nervous system damage that generates neuropathic pain, it has become a ubiquitous health concern without respect for geographic or socioeconomic boundaries [1]. Within the developing world, infectious diseases [2][3][4] and trauma [5] are the most common sources of neuropathic pain syndromes. The developed world, in contrast, suffers more frequently from diabetic polyneuropathy (DPN) [6,7], post herpetic neuralgia (PHN) from herpes zoster infections [8], and chemotherapy-induced peripheral neuropathy (CIPN) [9,10].…”

Section: Introductionmentioning

confidence: 99%